A retrospective review of cardiac events occurring in all patients who underwent attempted coronary angioplasty in the first 5 years of our experience (1980-1985) was undertaken. Follow-up data were obtained from the civil registry, hospltal records, patient, family, and referring physician. Patient survival curves were constructed and the outcome of women and men was compared. Eight hundred fifty-six patients, 172 women and 684 men with a mean age of 60.0 and 55.3 years, respectively, underwent attempted coronary angioplasty with an overall procedural success rate of 82%, 77.7% in women and 83.1% In men. Follow-up data were obtained in 837 patients (97.8%) with a mean period of 9.6 years (range 0-13.3 years).
INTRODUCTION
Despite major advances in the management of coronary artery disease, not only in surgical and interventional techniques but also in the identification and management of coronary risk factors, it remains the leading cause of morbidity and mortality in both men and women in the Western world. A number of recent reports have focused on the possible inequities in the management of women with obstructive coronary artery disease particularly with regard to revascularization procedures [ 1-31, However, when considering the utilization of these techniques, one must take into account the relative risks and benefits of such procedures. It is important to recognize a difference in the demographic, clinical, and angiographic profile of women when compared with men. Women on average are older and have more cardiac risk factors than men and in addition generally have a higher prevalence of unstable angina and congestive heart failure at the time of intervention. The in-hospital mortality after percutaneous transluminal coronary angioplasty (PTCA) increases with age and is higher in women than in men [4-61. The purpose of this study was to examine the longterm outcome following coronary angioplasty in women compared with men accepting the expected referral bias based on the above observations.
SUBJECTS AND METHODS Patients
Between September 1980 and December 1985, PTCA was attempted in 856 consecutive patients, 172 women and 684 men. Patient characteristics are displayed in Table I. The indication for angioplasty was stable angina in 451 patients, unstable angina in 323, acute myocardial infarction in 76, and other indications in 6. All patients were treated with a combination of beta-blockers, cal- cium channel blockers, nitrates, and in unstable cases intravenous heparin.
Angioplasty Technique
At the commencement of the procedure 250 mg acetylsalicylic acid and 100 mg heparin were administered intravenously, with additional boluses of 50 mg given hourly. Following completion of the procedure, if the stability of the immediate result was in doubt, a heparin infusion was commenced to achieve an activated partial thromboplastin time of 2.0-2.5 times control for 12-24 h. All patients continued to receive 40-60 mg nifedipine and 500 mg acetylsalicylic acid daily for a period of at least 6 months. The method of coronary angioplasty changed in February 1983 when the non-steerable catheter system originally described by Griientzig et al. [7] was replaced by steerable balloon systems [S]. During the study period the angioplasty balloons used were minimally compliant, disposable, and inflated to 6-8 atmospheres in both men and women. Procedural clinical success was defined as a reduction in the luminal narrowing to less than 50% of the reference diameter, by visual assessment, with no major complications, namely, death, myocardial infarction, coronary artery bypass grafting, or repeat angioplasty, within 24 hr of the procedure. Evidence of myocardial infarction immediately after the procedure was defined by a new Q wave andor elevation of myocardial enzymes to more than twice the upper limit of normal.
Data Collection and Follow-Up
Procedural details including maximum balloon size used and complications were recorded at the time of the procedure and entered into a dedicated data base. Procedure-related events were included in all follow-up analyses. All patients who survived hospital were initially checked against the civil registry to establish survival or death. This is a reliable and complete source of mortality data in The Netherlands. Primary endpoints considered at follow-up were death, non-fatal myocardial infarction, recurrent angina pectoris requiring coronary artery bypass surgery, or repeat coronary angioplasty and eventfree survival. These data were retrospectively obtained from the patient by letter or telephone, from family, or from the family doctor, and checked against hospital records.
Assessment of late myocardial infarction in the follow-up period included a history of prolonged chest pain necessitating hospital admission and documentation of a myocardial infarction by electrocardiographic or enzyme criterion. Information on bypass surgery and repeat angioplasty was obtained from the patient and hospital data bases. Additionally, surviving patients were asked for information regarding symptoms of angina pectoris, graded according to the Canadian Cardiovascular Society classification [9] , any resultant limitation in activities, and current medication. Follow-up data were obtained on all but 19 (2.2%) patients, the majority of whom had moved abroad. The period of follow-up ranged from 0 to 13.3 years with a median of 9.6 years.
Statistical Methods
Differences between discrete variables were assessed with the chi-square test. Patient survival curves were constructed according to the method of Kaplan 
Overall Survival and Events
Six-hundred forty-one patients were alive (77%) and 196 were deceased 8-14 years after their initial angioplasty. One hundred forty-three (16.7%) patients had experienced a myocardial infarction and 220 (25.7%) had undergone coronary artery bypass surgery, 62 (7.2%) as an emergency procedure immediately after coronary angioplasty. Two hundred twenty-one patients underwent further angioplasty in the follow-up period, 81 (9.5%) within 6 months of the initial procedure.
Patient survival and event-free survival curves were calculated. The overall 5 and 10 year patient survivals were 90% [95% confidence interval (CI) 87.6-92.4%] and 78% (95% CI 75.0-81.0%), respectively, and the 10 year survival with freedom from death, myocardial infarction, coronary artery bypass surgery, or repeat coronary angioplasty was 36% (95% CI 32.0-40.0%; 5 60.6%). Long-term survival was significantly reduced in patients aged 1 6 0 years and in those with a history of previous myocardial infarction, multivessel disease, and impaired left ventricular function.
Influence of Gender
Women were significantly older than men at the time of initial angioplasty with a mean age of 60.0 compared with 55.3 years in men ( P < 0.001). Additionally, women had suffered fewer myocardial infarctions than men prior to intervention, 34.6% and 43.6%, respectively (P < 0.05). There were no significant differences in the other clinical parameters. Patient survival and event-free survival curves were constructed (Fig. 1 ). Survival at 10 years was identical for women and men at 79% (95% CI 72.6-85.4%) and 78% (95% CI 74.6-81.4%), respectively (5 year survival 91% women, 90% men), as was the incidence of clinical events at 36% (95% CI 32.0-40.0%) for men and 37% (95% CI 29.2-44.8%) for women with a similar proportion of myocardial infarctions, bypass operations, and repeat coronary angioplasty procedures in the follow-up period (Table  11 ). The mean maximum balloon size used differed between women and men with respective mean diameters of 2.90 and 3.04 mm (P < 0.0005) ( sel size, assuming a reference vessel to balloon size ratio of 1: 1, then women undergoing angioplasty in the study period had significantly smaller vessels than men. A question that arises from these findings is whether long-term outcome in women is in fact superior to a similar group of men when the negative influences on outcome are taken into account. We therefore matched 172 women with 172 men for age (mean age women 60.03 years, standard deviation 8.07 years vs. mean age men 60.01 years, standard deviation 8.09 years) and previous myocardial infarction (both groups 55 previous infarction, 104 no previous infarction, 13 unknown), factors associated with an adverse outcome, which differed significantly between the two groups; there was no significant difference in 10 year survival (Fig. 2) . When we matched 143 women with 143 men for balloon size and compared long-term outcome, there was again no significant difference (P = 0.27) (Fig. 3) .
Details of symptomatic status and cardiac medication were obtained in 630 of the 648 survivors (98%). Angina class, the degree of limitation in 293 of 296 patients with angina, and the number of different antianginal medications from the classes nitrate, beta-blocker, and calcium channel blocker are displayed in Table IV . Significantly more surviving women than men experienced angina with 59.2% and 44%, respectively, suffering anginal symptoms at the time of interview (P < 0.05). In these patients, there was a similar distribution between angina classes 1-111 and objective assessment of limitation in activities. Women also took significantly more antianginal medication with 70% on at least one agent compared with 57% of men.
DISCUSSION
Women appear to delay the onset of clinically manifest coronary disease by 4-5 years when compared with men, which is most likely related to the premenopausal protective effect of estrogen [ 1 1,121, and one must question whether the older age at presentation results in lower referral and acceptance rates for coronary interventions, possibly explaining the much smaller proportion of women who undergo such procedures. Twenty percent of patients undergoing coronary angioplasty in our institution in the years 1980-1985 were women and they Overall 5 year survival was 90% (91% for women and 90% for men) which, although favorable, appears to be at the lower limit of previously reported data, where 5 year survival ranges from 89.2 to 96.3% [16-181. However, one must recognize the variation in patient populations; e.g., one may expect a better outcome following a successful angioplasty in a patient with stable angina and single vessel disease, where the prognosis is excellent even with medical therapy [19] . In our study, all patients in whom coronary angioplasty was attempted were included for analysis including those with angioplasty for an acute myocardial infarction. We felt this population more closely resembles the cross-section of current angioplasty practice. Several studies have found that outcome in terms of survival and major cardiac events, up to 5 years following angioplasty, is similar in women and men once the higher rate of in-hospital events has been accounted for [4,6,13]. These observations have been extended to the long-term by our study. Ten year survival was 79% for women and 78% for men and event-free survival was identical at 36%. When women and men were matched for age and a history of a previous myocardial infarction, factors found to be associated with a significantly poorer long-term outcome in our study, no significant difference was found. One can suggest that a balance has been found between the favorable and non-favorable clinical factors in the selection of women referred for interventional procedures such that their outcome in the long-term is the same as that for men. The only other study reporting 10 year survival is that of King and Schlumpf [20] , who described the long- Severe limitation 17.6 None or aspirin 29.8 Single therapya
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Bell et al. [4] Kelsey et al. [6] Weintraub et al. [13] McEniery et al. [14] Arnold et al. [15] Present study nary Artery Surgery Study (CASS) registry patients who were initially assigned surgical management was 70% for women and 73% for men [21] . The influence of vessel size on outcome has been of interest and is relevant when comparing the outcome of coronary angioplasty in men and women. The outcome of surgical revascularization in women who have a smaller body surface area has been reported to be less favorable than in men [22, 23] . It has been found that adjusting for body surface area, a surrogate for coronary artery size [24] , appears to remove the influence of gender on immediate outcome following coronary angioplasty [15, 25] and that a larger body surface area may confer a more favorable long-term outcome [ 131. As an estimation of coronary vessel size we used the nominal size of the largest angioplasty balloon used during angioplasty procedure. We believe the assumption of a 1:l ratio of maximal balloon size to reference vessel diameter, or at least a consistent ratio in men and women, to be a valid one, although making this assumption in the absence of data remains a limitation of our study. The maximum balloon size was significantly smaller in women, thus suggesting smaller coronary arteries. When men and women were matched for this variable there was no significant difference in long-term outcome, although there was a trend toward improved event-free survival in women. The reasons are speculative but may be related to the superior cardiac status of women at the time of intervention as outlined above. Additionally, it has been suggested recently that atherosclerotic lesions in women are less likely to have calcium than lesions with a similar degree of luminal narrowing in men [26] , the presence of calcium being a factor associated with a less favorable procedural result [27] .
Our finding of significantly more angina in surviving women than in men (59% vs. 44%) is consistent with the findings of others, with women appearing to have a 20-40% increased chance of suffering anginal symptoms at follow-up than men [6, 13, 14] . Additionally, women in our study took significantly more antianginal medication (beta-blocker, calcium channel blocker, and/or nitrate) than men, an observation also previously reported [6, 141. Thus, it appears that for a comparable risk of an adverse cardiac event in the long-term, women achieve less symptomatic relief than men.
CONCLUSIONS
Women selected to undergo PTCA are older, have more unstable angina, and on the whole have less complex cardiac disease than men. Their long-term prognosis following attempted coronary angioplasty is good and identical to that of men with respect to survival and incidence of major cardiac events. However, in the longterm, women are more likely to retain or have a recurrence of anginal symptoms and more frequently require antianginal medication than men.
